“Everyone was cordial and professional. Dr. Paul Lagonigro was personable and performed an outstanding eye exam with modern equipment. He explained results clearly and outlined future treatment paths.”
Anti-VEGF Eye Injections: What to Expect
Anti-VEGF Medications We Use
Several anti-VEGF medications are available, and each has its own profile of approvals, dosing intervals, and characteristics. Your retina specialist will recommend the medication best suited to your diagnosis and how your eye responds over time.
Lucentis (ranibizumab) was the first anti-VEGF drug approved specifically for use in the eye. It is FDA-approved for wet AMD, DME, diabetic retinopathy, and retinal vein occlusions. It is typically given every four weeks, though some patients may move to an extended schedule based on their response. Biosimilar versions of ranibizumab are also available and have the same active ingredient.
Eylea (aflibercept) is one of the most widely used anti-VEGF agents and is approved for wet AMD, DME, diabetic retinopathy, and retinal vein occlusions. After initial monthly loading doses, it is typically given every four to eight weeks. Eylea HD is a higher-concentration formulation approved for wet AMD and DME. This increased dose may allow some patients to go longer between injections after completing the loading phase.
Avastin (bevacizumab) was originally FDA-approved for certain cancers but is widely used off-label for retinal conditions. Large, rigorous clinical studies have demonstrated its effectiveness for wet AMD and other retinal diseases. Many retina specialists use Avastin because of its well-established performance in major research trials. It is typically given every four to six weeks.
Vabysmo (faricimab) works differently from other anti-VEGF drugs. It is a bispecific antibody, meaning it targets two proteins involved in retinal disease: VEGF and angiopoietin-2 (Ang-2), which also plays a role in blood vessel stability. This dual action may provide more complete disease control. Vabysmo is approved for wet AMD and DME, and some patients may be able to go up to four months between injections, which can reduce the number of office visits needed each year.
Who May Need Anti-VEGF Treatment
Certain health conditions and lifestyle factors raise the risk of developing retinal diseases that require anti-VEGF therapy. Knowing your risk can help you stay ahead of potential vision changes.
Advanced age is the primary risk factor for wet AMD, the most common condition treated with anti-VEGF injections. Risk increases significantly after age 60. A family history of AMD also raises your likelihood of developing the condition. If a close relative has been diagnosed with AMD, talking with your eye care provider about screening is a good step.
Diabetes is the leading cause of diabetic retinopathy and diabetic macular edema. The longer a person has diabetes and the less controlled their blood sugar, the greater their risk of retinal complications. High blood pressure and cardiovascular disease also contribute to retinal vascular problems, including retinal vein occlusions. Managing these systemic conditions can help protect your retinal health over time.
Smoking is one of the most significant modifiable risk factors for AMD. Quitting smoking at any age can reduce this risk. A diet rich in leafy greens, fish, and antioxidants may help support retinal health. These lifestyle measures do not replace medical treatment once a condition has developed, but they can play a meaningful role in protecting your eyes alongside professional care.
Symptoms That May Lead to a Referral
Retinal conditions can cause a wide range of vision changes, from slow and subtle shifts to sudden and alarming symptoms. Recognizing what to watch for, and knowing when to act urgently, can make a real difference in your outcome.
Many retinal conditions develop slowly. Early signs may include blurred central vision, difficulty reading, and a need for brighter light. Straight lines may appear wavy or distorted, a symptom called metamorphopsia. These changes can be subtle at first and may only affect one eye, which makes them easy to overlook. Regular eye exams are important for catching these signs early.
Some retinal conditions cause sudden symptoms that require immediate attention. A rapid increase in floaters, flashes of light, a shadow spreading across part of your vision, or sudden vision loss in one eye are warning signs of a serious problem. If you experience any of these symptoms, see a retina specialist or go to an emergency room right away. Delaying care can result in severe and irreversible vision loss.
How We Diagnose Retinal Conditions
Before recommending anti-VEGF treatment, our team will perform a thorough evaluation of your retina. The imaging and testing we use gives us a precise, detailed picture of what is happening inside your eye.
A retina specialist will start with a comprehensive dilated eye exam. Eye drops widen the pupil so the specialist can examine the retina in detail. This exam can reveal abnormal blood vessels, fluid buildup, bleeding, and other signs of retinal disease. Visual acuity testing measures how clearly you see at different distances and gives us a useful baseline for tracking changes over time.
Optical coherence tomography, or OCT, is a noninvasive imaging test that creates detailed, cross-sectional pictures of the retina. It can detect fluid under or within the retinal layers, measure retinal thickness, and reveal structural changes at a microscopic level. OCT is one of the most important tools we use to diagnose retinal conditions and track how well treatment is working over time. We also offer OCT angiography, which shows blood flow in the retinal layers without the need for a dye injection.
Fluorescein angiography uses a special dye to photograph blood flow in the retina. The dye is injected into a vein in the arm and reaches the eye within seconds, allowing a specialized camera to capture images that show leaking vessels, poor blood flow, and abnormal vessel growth. This information helps us plan the most appropriate treatment for your specific situation. We also offer indocyanine green angiography when a more detailed view of deeper retinal structures is needed.
The Injection Procedure
The idea of an injection in the eye can feel daunting, but the procedure is quick and most patients are surprised by how manageable it is. Understanding what happens before, during, and after can help ease anxiety.
Before the injection, the eye is cleaned with an antiseptic solution to reduce infection risk. Numbing drops or a small injection of local anesthetic is applied to minimize discomfort. A small device called a lid speculum may be used to keep the eyelids gently open. The preparation process typically takes just a few minutes.
The injection is given with a very fine needle inserted through the white part of the eye, called the sclera, and into the vitreous cavity, the gel-filled space inside the eye. The medication is delivered in a very small volume. Most patients describe the sensation as brief pressure rather than sharp pain. The injection itself takes only a few seconds, and the full office visit, including preparation and a brief check afterward, usually lasts about 30 minutes.
Right after the injection, you may notice floaters, mild redness on the white of the eye, or a gritty feeling. These are normal and typically resolve within a few days. Your retina specialist may check your eye pressure before you leave the office. Most people can return to their normal activities the same day, though your care team will give you specific instructions to follow.
Treatment frequency depends on the medication used and how your eye responds. Many patients begin with monthly loading doses, typically three to four injections spaced four weeks apart. After that phase, your retina specialist may extend the interval between visits using a treat-and-extend approach. With newer agents like Vabysmo and Eylea HD, some patients can go several months between injections. Individual needs vary, and your schedule will be adjusted based on ongoing monitoring.
What to Expect from Treatment
Anti-VEGF therapy has transformed the outlook for patients with serious retinal conditions. Knowing what the treatment can realistically achieve, and what requires your active participation, is an important part of planning for the long term.
For many patients, anti-VEGF treatment helps stabilize vision and, in some cases, can improve it. Results vary depending on the condition being treated, how advanced the disease was at the time treatment began, and how consistently the treatment schedule is followed. The primary goal is to preserve your current vision and prevent further loss. Not every patient will experience an improvement, but consistent treatment gives you the best opportunity for a favorable outcome.
Anti-VEGF therapy is not a one-time procedure. Skipping or delaying injections can allow the disease to reactivate, leading to new fluid leakage and additional vision loss that may not be recoverable. Keeping all scheduled appointments is one of the most important things you can do to protect your sight. If work, transportation, or other barriers make it difficult to attend regularly, please talk with our team so we can help find a solution.
Anti-VEGF injections have a strong safety record and the most common side effects are minor and temporary, including mild redness, floaters, and a gritty or sore feeling. Serious complications are rare. The most concerning potential complication is endophthalmitis, a severe infection inside the eye. Though uncommon, endophthalmitis is a medical emergency. Seek immediate care if you develop severe eye pain, significant vision loss, increasing redness, or discharge from the eye within days of an injection.
Living with Long-Term Anti-VEGF Treatment
Because anti-VEGF therapy is often a long-term commitment, building habits and support systems around your treatment can make a meaningful difference in your quality of life and your ability to stay on track.
Using a calendar, phone reminders, or asking a family member to help track appointments can make it easier to stay consistent. Some patients find it helpful to schedule injection visits on a regular day of the week or coordinate them with other errands. The more routine the visits become, the easier it is to maintain the schedule that protects your vision.
Between appointments, you can check your vision with an Amsler grid, a simple chart with a grid of straight lines and a central dot. Looking at the grid with each eye separately can help you detect new distortion, blurriness, or missing areas. These changes may indicate that your condition is becoming more active. Report any new changes promptly rather than waiting for your next scheduled visit, as early intervention often leads to better outcomes.
Living with a chronic eye condition and undergoing regular injections can be stressful. It is entirely normal to feel anxious before appointments or concerned about your long-term vision. Talking openly with family, friends, or a counselor can help. Low-vision rehabilitation services and patient support groups are also available for those who have experienced significant vision changes and need practical guidance on daily living.
Frequently Asked Questions
These answers address practical questions our patients commonly raise after learning about anti-VEGF treatment.
Most patients are genuinely surprised by how little discomfort is involved. Numbing drops or local anesthetic are applied before the injection, and the injection itself takes only a few seconds. The most common description is a feeling of brief pressure. Some mild soreness or irritation may follow and typically resolves within a day or two. If discomfort is significant or lasts longer than expected, let your retina specialist know at your next visit.
For most conditions treated with anti-VEGF therapy, such as wet AMD and diabetic eye disease, treatment is ongoing because the underlying disease is chronic. Stopping injections entirely can allow the disease to reactivate. However, as your condition stabilizes, your retina specialist may be able to gradually extend the time between injections. The goal is always to find the longest safe interval that still controls your disease activity.
All commonly used anti-VEGF medications are effective, but they differ in molecular structure, how long they remain active in the eye, their dosing intervals, and their FDA-approved uses. Vabysmo, for instance, targets a second protein involved in retinal disease, which may offer more complete control in some patients. Eylea HD offers a higher dose that may allow longer intervals between injections. Avastin has an off-label use in the eye but is supported by extensive clinical research. Your retina specialist will choose the medication that best fits your specific condition and response pattern.
For most patients with wet AMD, DME, or retinal vein occlusions, anti-VEGF injections are the most effective treatment currently available. In certain situations, retinal laser photocoagulation or steroid-based implants such as Iluvien may be used alongside or instead of injections, depending on the condition. Research into sustained-release implants and other delivery methods is ongoing, and options may expand over time. Your retina specialist can explain which alternatives, if any, are appropriate for your specific situation.
Do not wait for your next scheduled appointment if you notice new or worsening symptoms. A sudden increase in floaters, new flashes of light, a shadow over part of your vision, or a sudden drop in vision are warning signs that require urgent evaluation. These symptoms can indicate serious complications such as endophthalmitis, a new retinal tear, or retinal detachment. Contact our office right away or go to an emergency room if symptoms appear severe or develop rapidly.
Nutritional supplements formulated for macular health, particularly those based on the AREDS or AREDS 2 formula, are commonly recommended alongside anti-VEGF treatment for certain conditions like dry AMD. Supplements do not replace anti-VEGF therapy, but they may play a supportive role in slowing disease progression in appropriate patients. Our team can advise you on whether a supplement is suitable for your diagnosis and which formulation may be most relevant to your situation.
Schedule a Consultation at Atlantic Retina Center
Our team of fellowship-trained, board-certified retina specialists is dedicated to providing expert, compassionate care for patients throughout the Delmarva peninsula. We combine advanced diagnostic imaging, including serial retinal photo comparisons at every visit, with the full range of anti-VEGF treatment options to give you the most complete picture of your retinal health. If you have been diagnosed with a retinal condition or are experiencing vision changes, we encourage you to contact Atlantic Retina Center and take the next step toward protecting your sight.